Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review

J Yang, R Xu, C Wang, J Qiu, B Ren… - Cancer …, 2021 - Wiley Online Library
Pancreatic cancer is a highly malignant digestive system tumor with a poor prognosis. Most
pancreatic cancer patients are diagnosed at an advanced stage or even metastasis due to …

Measurement and analysis of cancer biomarkers based on electrochemical biosensors

F Cui, Z Zhou, HS Zhou - Journal of The Electrochemical Society, 2019 - iopscience.iop.org
Cancer is a dreadful disease with a high mortality rate, and it has become more and more
prevalent worldwide. Early diagnosis, prognosis and treatment monitoring with robust and …

[HTML][HTML] A faecal microbiota signature with high specificity for pancreatic cancer

E Kartal, TSB Schmidt, E Molina-Montes… - Gut, 2022 - gut.bmj.com
Background Recent evidence suggests a role for the microbiome in pancreatic ductal
adenocarcinoma (PDAC) aetiology and progression. Objective To explore the faecal and …

Electrochemical biosensors for detection of microRNA as a cancer biomarker: Pros and cons

M El Aamri, G Yammouri, H Mohammadi, A Amine… - Biosensors, 2020 - mdpi.com
Cancer is the second most fatal disease in the world and an early diagnosis is important for
a successful treatment. Thus, it is necessary to develop fast, sensitive, simple, and …

Surface plasmon resonance: A promising approach for label-free early cancer diagnosis

A Gade, A Sharma, N Srivastava, SJS Flora - Clinica Chimica Acta, 2022 - Elsevier
Cancer is the second leading cause of death worldwide after cardiovascular disease. The
major cause of high mortality is delayed detection. Therefore, detection at an early stage …

Early diagnosis and management of malignant distal biliary obstruction: a review on current recommendations and guidelines

M Fernandez Y Viesca, M Arvanitakis - Clinical and Experimental …, 2019 - Taylor & Francis
Malignant biliary obstruction is a challenging condition, requiring a multimodal approach for
both diagnosis and treatment. Pancreatic adenocarcinoma and cholangiocarcinoma are the …

Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?

MJ Duffy, EP Diamandis, J Crown - Clinical Chemistry and …, 2021 - degruyter.com
The detection of cancer at an early stage while it is curable by surgical resection is widely
believed to be one of the most effective strategies for reducing cancer mortality. Hence, the …

Biosensors for cancer biomarkers based on mesoporous silica nanoparticles

M Mladenović, S Jarić, M Mundžić, A Pavlović… - Biosensors, 2024 - mdpi.com
Mesoporous silica nanoparticles (MSNs) exhibit highly beneficial characteristics for devising
efficient biosensors for different analytes. Their unique properties, such as capabilities for …

Diagnostic accuracy of blood-based biomarkers for pancreatic cancer: a systematic review and meta-analysis

LE Kane, GS Mellotte, E Mylod, RM O'Brien… - Cancer research …, 2022 - AACR
Pancreatic ductal adenocarcinoma (PDAC) has a 5-year survival rate below 5%.
Carbohydrate antigen 19-9 (CA19-9) is the most commonly used blood-based biomarker for …

Serum tumor markers for early diagnosis of primary hepatocellular carcinoma

J Zong, Z Fan, Y Zhang - Journal of hepatocellular carcinoma, 2020 - Taylor & Francis
Primary hepatocellular carcinoma (HCC) is one of the most frequently occurring pernicious
tumors in the world. It is typically very insidious in the early stages with no obvious …